Almost half (47%) of the world’s population is the main tests and services essential for diagnosing common diseases such as diabetes, high blood pressure, HIV and tuberculosis, or the basics of pregnant women such as hepatitis B and hepatitis B. Access to the test is restricted or not at all. According to a new analysis, syphilis. Without access to accurate, high-quality, and affordable diagnostics, many are exposed to over-treatment, under-treatment, or no treatment or unnecessary and potentially harmful treatment.
The analysis was led by The Lancet Commission on Diagnostics, a detailed report that brought together 25 experts from 16 countries to transform global access to diagnostics.The Commission emphasizes the diagnostic centrality of functioning health systems and calls on policy makers to bridge diagnostic gaps, improve access and extend beyond the development of diagnostics. High-income countries..
As the Commission points out, the early lesson of the COVID-19 pandemic was the crucial importance of timely and accurate diagnosis. Early problems in developing tests hindered understanding and response to occurrences, leading to the rapid emergence of unreliable, inaccurate (wrong) tests. In high-income countries, the ability to utilize existing public health laboratories in addition to the private sector was important for improving testing capacity, but many low- and middle-income countries that do not have access to this infrastructure are at a disadvantage and complete. The capacity that could not reach the test.
“In many parts of the world, patients are being treated for their illness without access to major diagnostic tests and services. This is the same as blindly practicing medical care. It is harmful to patients. Not only possible but also scarce medical resources Our analysis shows for the first time the shocking scale of the challenges we face, and our report shows how we are. We provide recommendations on how to close the gap, said Dr. Kenneth Fleming, Chairman of Oxford University (UK).
Diagnosis includes a collection of key tests and services that are essential to understanding a patient’s health. These may include blood, tissue, or urine samples collected and analyzed at the bedside or in the laboratory, or diagnostic imaging such as x-rays, ultrasound, MRI, CT, or nuclear medicine.
As part of the committee, the authors have access to tests for prenatal care recommended by the World Health Organization (WHO) to provide global estimates of access to basic diagnoses. We have reviewed the best data. These tests, such as syphilis test, general urinary substance determination, hemoglobin test, blood glucose test, and ultrasound, are essential diagnostic tests and must be available within the patient’s travel time of 2 hours.
Diagnosis is the basis of quality medical care, but as the Commission states, this concept is not well recognized and leads to underfunding and inadequate resources at all levels. Globally, they estimate that nearly half (47%) of the population lack access to diagnosis. The diagnostic gap is the largest in primary care, with only about 19% of the population of low- and middle-income countries having access to the simplest countries. Diagnostic test (Excluding HIV or malaria). The authors call for urgent investment and training to improve access to primary care testing, especially the Point of Care testing.
“There are three essentials to health safety. Diagnostic safety, vaccine safety, and therapeutic safety. A strong health system and a strong public health system require all three. Fairness is. We start by regionalizing the production of health and safety products as much as possible, including diagnosis, “said Dr. John Nkengason, director of the African Center for Disease Control and Prevention and co-author of the Commission. Stated.
At world level, narrowing the diagnostic gap for just six conditions (diabetes, hypertension, HIV, tuberculosis, as well as hepatitis B and syphilis in pregnant women) from 35-62% to 10% causes early deaths of low-income earners annually. The number will decrease. -1.1 million income and middle income countries.
The key to bridging the diagnostic gap is the availability of trained staff, and the Commission estimates a global shortage of up to 1 million diagnostic staff, which must be addressed through training and education. It will not be. “Without a skilled workforce that can maximize education and training, countries cannot provide access to diagnostics suitable for each level of care and achieve universal health insurance,” said Vice-Chair. Professor Michael Wilson said. Chairman of the Commission, Denver Health Hospital Department (USA).
The Commission further recommends that countries urgently develop national diagnostic strategies based on providing the population with access to a set of essential diagnostics tailored to the medical needs of the region.
Over the last 15 years, there have been extraordinary innovations in technology and informatics to transform diagnostics, but the Commission warns that the benefits are not being shared fairly. The global market for in vitro diagnostics and diagnostic imaging is valued at US $ 843 billion. High-income countries dominate, with only four companies in the United States and Europe accounting for half of the global supply of in vitro diagnostics, and four companies in the United States, Europe and Japan accounting for three-quarters of the global supply of imaging equipment. ..
“The COVID-19 pandemic presents the risks associated with relying on a small number of healthcare suppliers. More research, development, lower production and lower production. Middle income country Is an important priority, “said Professor Susan Houghton, Vice-Chair of the Committee at the University of Waterloo (Canada).
Other recommendations from the Commission include affordable improvements, strengthened regulatory frameworks to monitor diagnostic quality and safety, and democratization of diagnostics (point of care testing, self-sampling, self-testing). Increased availability) is included.
Dr. Sabine Kleinert, Senior Executive Editor and Dr. Richard Horton, Editor-in-Chief, Write Linked Comments Lancet Addition: “Rapid lateral flow of SARS-CoV-2, PCR, and antigen testing are discussed daily by politicians, journalists, and the general public, and at least in many high-income countries, at home. Available for self-use or in public places. Genetic testing for early identification of SARS-CoV-2 variants helps monitor the spread of the virus and informs vaccine strategies. Diagnostic capabilities. This rapid need for and inspection further exacerbates inequality and demonstrates deficiencies in manufacturing and capacity in the countries where it is needed, raising the ugly ghost of nationalism as a response to the most and global emergencies. Did … More attention to diagnosis as a fundamental element of the health system not only helps end the COVID-19 pandemic and strengthens its readiness to fight future pandemics, but also prevents common illnesses, Very important for quality health care and improvement health It is producing results worldwide. ”
The Lancet Committee on Diagnosis: Transforming Access to Diagnosis, Lancet (2021). DOI: doi.org/10.1016/S0140-6736 (21) 00673-5
The report will be presented at a virtual event co-sponsored by FIND, a global diagnostic alliance, at 1:00 pm on Thursday, October 7, UK time. Register for free: https://finddx.zoom.us/webinar/register/WN_VZXIezXdTwmF6jeXnYcgog
Quote: Lancet: Half of the world’s population is a number of common illnesses acquired on October 6, 2021 from https: //medicalxpress.com/news/2021-10-lancet-global-population-lack (2021) Lacking access to basic diagnostics (October 6)-access.html
This document is subject to copyright. No part may be reproduced without written permission, except for fair transactions for personal investigation or research purposes. The content is provided for informational purposes only.
Half of the global population lack access to basic diagnostics for many common diseases Source link Half of the global population lack access to basic diagnostics for many common diseases